NasdaqGS - Delayed Quote USD

Opthea Limited (OPT)

Compare
5.07
+0.06
+(1.20%)
At close: January 29 at 4:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
124.67
124.67
108.41
90.68
68.61
Cost of Revenue
--
--
166.83
160.50
428.90
Gross Profit
--
--
-58.42
-69.82
-360.29
Operating Expense
191,967.40
191,967.40
149,967.37
96,468.15
39,281.66
Operating Income
-191,842.73
-191,842.73
-150,025.79
-96,537.96
-39,641.95
Net Non Operating Interest Income Expense
-26,868.32
-26,868.32
-10,234.66
235.47
372.00
Other Income Expense
-10,943.25
-10,943.25
11,813.02
-2,814.16
-11,013.40
Pretax Income
-229,654.30
-229,654.30
-148,447.44
-99,116.66
-50,283.34
Tax Provision
-9,412.20
-9,412.20
-5,926.35
-6,299.29
-4,938.85
Net Income Common Stockholders
-220,242.11
-220,242.11
-142,521.09
-92,817.37
-45,344.50
Diluted NI Available to Com Stockholders
-220,242.11
-220,242.11
-142,521.09
-92,817.37
-45,344.50
Basic EPS
-2.22
--
-2.24
-1.83
-0.98
Diluted EPS
-2.22
--
-2.24
-1.83
-0.98
Basic Average Shares
72,252.08
--
63,725.44
50,613.28
46,131.94
Diluted Average Shares
72,252.08
--
63,725.44
50,613.28
46,131.94
Total Operating Income as Reported
-191,842.73
-191,842.73
--
--
--
Rent Expense Supplemental
--
--
--
21.31
18.45
Total Expenses
191,967.40
191,967.40
150,134.20
96,628.65
39,710.56
Net Income from Continuing & Discontinued Operation
-220,242.11
-220,242.11
-142,521.09
-92,817.37
-45,344.50
Normalized Income
-209,375.94
-209,375.94
-142,051.48
-90,182.06
-35,412.84
Interest Income
3,394.73
3,394.73
3,227.50
235.47
372.00
Interest Expense
30,263.04
30,263.04
13,462.16
--
--
Net Interest Income
-26,868.32
-26,868.32
-10,234.66
235.47
372.00
EBIT
-199,391.26
-199,391.26
-134,985.28
-99,116.66
-50,283.34
EBITDA
-199,288.23
-199,288.23
-134,884.05
-99,038.28
-50,176.67
Reconciled Cost of Revenue
--
--
166.83
160.50
428.90
Reconciled Depreciation
103.03
103.03
101.23
78.38
106.67
Net Income from Continuing Operation Net Minority Interest
-220,242.11
-220,242.11
-142,521.09
-92,817.37
-45,344.50
Total Unusual Items Excluding Goodwill
-11,330.54
-11,330.54
-489.14
-2,814.16
-11,013.40
Total Unusual Items
-11,330.54
-11,330.54
-489.14
-2,814.16
-11,013.40
Normalized EBITDA
-187,957.70
-187,957.70
-134,394.91
-96,224.11
-39,163.28
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-464.37
-464.37
-19.53
-178.85
-1,081.74
6/30/2021 - 10/16/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IMM.AX Immutep Limited
0.3500
+2.94%
 
OCS Oculis Holding AG
22.15
-0.81%
 
LTP.AX LTR PHARMA FPO [LTP]
0.7750
-1.90%
 
IMMP Immutep Limited
2.0500
+4.59%
 
NBTX Nanobiotix S.A.
3.4600
+3.59%
 
PLRZ Polyrizon Ltd.
1.3000
-9.09%
 
CU6.AX Clarity Pharmaceuticals Ltd
3.7400
-7.65%
 
LENZ LENZ Therapeutics, Inc.
25.18
-4.08%
 
CNTA Centessa Pharmaceuticals plc
16.96
+2.23%
 
INVA Innoviva, Inc.
18.89
+0.53%